These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1676255)

  • 1. Dopaminergic drug therapy in patients with hyperprolactinemia that is difficult to treat.
    Pepperell RJ
    Ann N Y Acad Sci; 1991; 626():431-7. PubMed ID: 1676255
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolactin bioassay and hyperprolactinemia.
    Peabody CA; Schultz PN; Warner MD; Worsley IG; Friesen HG; Samaan NA
    J Endocrinol Invest; 1992; 15(7):497-9. PubMed ID: 1360020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cabergoline: an advance in dopaminergic therapy.
    Bevan JS; Davis JR
    Clin Endocrinol (Oxf); 1994 Dec; 41(6):709-12. PubMed ID: 7889603
    [No Abstract]   [Full Text] [Related]  

  • 4. [Medical treatment of hyperprolactinemic states using lisuride, a prolonged-action dopaminergic].
    Zárate A; Fonseca ME; Moran C; Miranda R
    Gac Med Mex; 1988; 124(3-4):107-9. PubMed ID: 2905312
    [No Abstract]   [Full Text] [Related]  

  • 5. Progress in the management of hyperprolactinemia.
    Serri O
    N Engl J Med; 1994 Oct; 331(14):942-4. PubMed ID: 7915825
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperprolactinemia. Evaluation and management.
    Blackwell RE
    Endocrinol Metab Clin North Am; 1992 Mar; 21(1):105-24. PubMed ID: 1349524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperprolactinemia].
    Müller OA; von Werder K
    Z Arztl Fortbild (Jena); 1991 Feb; 85(3-4):125-30. PubMed ID: 1676201
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathological hyperprolactinemia suppresses hot flashes in menopausal women.
    Scoccia B; Schneider AB; Marut EL; Scommegna A
    J Clin Endocrinol Metab; 1988 Apr; 66(4):868-71. PubMed ID: 3346363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic treatments for hyperprolactinaemia.
    Crosignani PG; Ferrari C
    Baillieres Clin Obstet Gynaecol; 1990 Sep; 4(3):441-55. PubMed ID: 1980863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug and radiotherapy of pituitary tumors].
    Yoshida H; Takeda F; Kinouchi T; Shimizu N
    Nihon Rinsho; 1986 Mar; 44(3):659-66. PubMed ID: 3016373
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperprolactinemia: an unusual cause of erectile dysfunction.
    Anand KS; Dhikav V
    Arch Sex Behav; 2013 Apr; 42(3):341. PubMed ID: 23297150
    [No Abstract]   [Full Text] [Related]  

  • 12. Is pregnancy the best treatment for hyperprolactinaemia?
    Crosignani PG; Mattei AM; Scarduelli C; Cavioni V; Boracchi P
    Hum Reprod; 1989 Nov; 4(8):910-2. PubMed ID: 2575622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinaemia--a clinical study with special reference to long-term follow-up, treatment with dopamine agonists, and pregnancy.
    Rasmussen C
    Ups J Med Sci; 1990; 95(1):1-29. PubMed ID: 1977229
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current diagnosis and treatment of hyperprolactinemia].
    Melgar V; Espinosa E; Sosa E; Rangel MJ; Cuenca D; Ramírez C; Mercado M
    Rev Med Inst Mex Seguro Soc; 2016; 54(1):111-21. PubMed ID: 26820213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperprolactinemia and infertility.
    Shibli-Rahhal A; Schlechte J
    Endocrinol Metab Clin North Am; 2011 Dec; 40(4):837-46. PubMed ID: 22108283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation of hyperprolactinemia.
    Luciano AA
    J Reprod Med; 1999 Dec; 44(12 Suppl):1085-90. PubMed ID: 10649815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary production of prolactin and prolactin-suppressing drugs.
    Tansey MJ; Schlechte JA
    Lupus; 2001; 10(10):660-4. PubMed ID: 11721691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperprolactinaemia.
    Patel SS; Bamigboye V
    J Obstet Gynaecol; 2007 Jul; 27(5):455-9. PubMed ID: 17701788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-over study with the two novel dopaminergic drugs cabergoline and quinagolide in hyperprolactinemic patients.
    Giusti M; Porcella E; Carraro A; Cuttica M; Valenti S; Giordano G
    J Endocrinol Invest; 1994 Jan; 17(1):51-7. PubMed ID: 7911813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary dexamethasone-suppressible hyperaldosteronism and hyperprolactinemia].
    Veglio F; Pinna G; Rabbia F; Mulatero P; Chiandussi L
    Minerva Endocrinol; 1992; 17(1):43-6. PubMed ID: 1323053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.